By The ASCO Post Staff
Posted: 6/11/2026 9:49:00 AM
Last Updated:
Three commercially available radiology artificial intelligence (AI) systems have shown the potential to flag early signs of breast cancer up to 6 years before a diagnosis, according to a Swedish study published by Hickman et al in Radiology.
In a retrospective study, researchers tested three AI-based computer-assisted detection (AI-CAD) systems on mammogram data from a large screening population. They found that cancer prediction scores issued by AI-CAD were elevated, on average, for individuals who were eventually diagnosed with breast cancer, while scores were low for those who remained cancer-free.
“Approximately 20% of breast cancer cases demonstrate mammographic signs that are already visible to AI around 6 years before diagnosis,” explained senior coauthor Fredrik Strand, MD, PhD, of Karolinska University Hospital in Stockholm. “Our study confirms the potential of AI to, in some cases, find signs of cancer in the mammograms much earlier than when radiologists detected it.”
AI-based systems have shown promise for predicting 5-year risk of breast cancer and identifying women at risk of “interval” cancers between regular screening mammograms. Dr. Strand’s team investigated AI’s potential to flag mammographic signs that were present up to 10 years in retrospect.
For the study, the researchers included a total of 88,963 mammograms performed on 31,394 patients across a period of 10 years. Data were taken from the Validation of Artificial Intelligence for Breast Imaging (VAI-B) database, which collects breast imaging data from volunteers across four regions of Sweden. The Swedish national breast screening program invites women between the ages of 40 and 74 years to participate in screening examinations every 2 years, and each mammogram has traditionally been read by two radiologists.
Dr. Strand’s team applied three commercially available AI-CAD systems to mammograms taken between January 2008 and April 2019. Across that period, 12,072 of the participants (38.5%) were diagnosed with cancer by radiologist readers.
The AI-CAD systems successfully identified many of those cancers at earlier screening points, achieving 90% specificity—distinguishing between a true positive and a true negative result—in up to 19.7% of individuals 6 years before their recorded diagnosis, up to 25.2% of individuals 4 years before diagnosis, and up to 39.3% 2 years before diagnosis.
AI-CAD scores could help radiologists spot early mammographic signs of potential future cancers, and a personalized approach to interpreting individual scores could help identify patients who might benefit from closer vigilance.
“This study aims to add to the growing literature regarding the application of AI in breast cancer screening and how it can help play a role in earlier detection of breast cancer,” said Dr. Strand. “Analyzing the AI scores of screened individuals over time could provide insight into how early detectable changes arise, potentially allowing for earlier intervention.”
DISCLOSURE: For full disclosures of the study authors, visit pubs.rsna.org.
